Research theme for competitive and other funds (6):
2023 - 2027 長期凍結造血幹細胞におけるクローン性増殖の解析
2022 - 2026 抗がん化学療法患者における脳波モニタリングの有用性の検討
2022 - 2026 癌性悪液質治療薬を用いた抗がん化学療法患者の腸管免疫療法
2019 - 2022 生体リズムを利用した化学療法患者の菌血症の発症抑制
2016 - 2020 Antiemetic therapy with chronotherapy and phototherapy for patients with cancer chemotherapy
2015 - 2020 Immunonutritional therapy by induced gamma delta T cell in patients with cancer chemotherapy
Show all
Papers (41):
Hiroyuki Kubo, Osamu Imataki, Tetsuya Fukumoto, Tomoya Ishida, Yukiko Hamasaki Kubo, Jun ichiro Kida, Makiko Uemura, Haruyuki Fujita, Norimitsu Kadowaki. Prognostic impact of the simple L-index and absolute lymphocyte count early after allogeneic hematopoietic stem cell transplantation. Cytotherapy. 2023. 25. 4. 415-422
Osamu Imataki, Tomoya Ishida, Jun ichiro Kida, Makiko Uemura, Haruyuki Fujita, Norimitsu Kadowaki. Cost-Effectiveness Analysis of Transplantation-Ineligible Elderly Patients With Acute Leukemia Harboring a Molecular Target: Ph-Positive Acute Leukemia and FLT3-Mutated Acute Myeloid Leukemia. Journal of Clinical Medicine Research. 2022. 14. 10. 432-435
Osamu Imataki, Makiko Uemura, Haruyuki Fujita, Norimitsu Kadowaki. Application of PD-L1 blockade in refractory histiocytic sarcoma: A case report. Molecular and Clinical Oncology. 2022. 17. 3
Hiroyuki Kubo, Osamu Imataki, Tetsuya Fukumoto, Maki Oku, Tomoya Ishida, Yukiko Hamasaki Kubo, Jun ichiro Kida, Makiko Uemura, Haruyuki Fujita, Hirofumi Ohno, et al. Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2021. 27. 11. 949.e1-949.e8
Osamu Imataki, Shunsuke Yoshida, Tomohiro Kaji, Jun Ichiro Kida, Hiroyuki Kubo, Makiko Uemura, Haruyuki Fujita, Norimitsu Kadowaki. Distinct Characteristics of Sweet's Syndrome of the Scrotum Caused by All- trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia. Case Reports in Oncology. 2021. 14. 3. 1466-1474